Skip to main content
Log in

Mechanisms of Action of Ladasten: Activation of Gene Expression for Neurotrophins and Mitogen-Activated Kinases

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effects of single treatment with ladasten (50 mg/kg) on the content of effector kinases of the mitogen-activated cascade (ERK1/ERK2), pERK1/ERK2 activity (Thr202/Tyr204), and expression of genes for neurotrophic factors BDND and NGF in the striatum, hypothalamus, and hippocampus of rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yu. V. Vakhitova, R. S. Yamidanov, V. A. Vakhitov, and S. B. Seredenin, Mol. Biol., 39, No. 2, 276–285 (2005).

    Article  Google Scholar 

  2. E. B. Dubnitskaya and D. F. Pushkarev, Psikhicheskie Rasstroistva Obshchei Meditsine, No. 3, 34–39 (2010).

  3. A. B. Smulevich, A. V. Andryushchenko, and D. A. Beskova, Psikhiatr Psikhofarmakoter., 11, No. 1, 18–26 (2009).

    Google Scholar 

  4. J. P. Adams, E. D. Roberson, J. D. English, et al., Acta Neurobiol. Exp. (Wars.), 60, No. 3, 377–394 (2000).

    PubMed  CAS  Google Scholar 

  5. R. J. Davis, Mol. Reprod. Dev., 42, No. 4, 459–467 (1995).

    Article  PubMed  CAS  Google Scholar 

  6. Y. Hao, T. Creson, L. Zhang, et al., J. Neurosci., 24, No. 29, 6590–6599 (2004).

    Article  PubMed  CAS  Google Scholar 

  7. D. M. Juric, S. Miklic, and M. Carman-Krzan, Brain Res., 1108, No. 1, 54–62 (2006).

    Article  PubMed  CAS  Google Scholar 

  8. L. Lu, B. T. Hope, J. Dempsey, et al., Nat. Neurosci., 8, No. 2, 212–219 (2005).

    Article  PubMed  CAS  Google Scholar 

  9. R. C. Petersen, R. Doody, A. Kurz, et al., Arch. Neurol., 58, No. 12, 1985–1992 (2001).

    Article  PubMed  CAS  Google Scholar 

  10. A. Pillai, J. Terry, and S. Mahadik, Schizophr. Res., 82, No. 1, 95–106 (2006).

    Article  PubMed  Google Scholar 

  11. D. S. Russell and R. S. Duman, Neuropsychopharmacology: The Fifth Generation of Progress — American College of Neuropsychopharmacology, Eds. K. L. Davis et al., Philadelphia (2002), pp. 208–217.

  12. E. Valjent, A. G. Corbille, J. Bertran-Gonzales, et al., Proc. Natl. Acad. Sci. USA, 103, No. 8, 2932–2937 (2008).

    Article  Google Scholar 

  13. Q. Wu, R. H. Miller, R. M. Ransohoff, et al., J. Neurosci., 20, No. 7, 2609 (2000).

    PubMed  CAS  Google Scholar 

  14. U. Wyneken, M. Sandoval, S. Sandoval, et al., Neuropsychopharmacology, 31, No. 11, 2415–2423 (2006).

    Article  PubMed  CAS  Google Scholar 

  15. X. Zhanga, E. Andrenb, and P. Svenningsson, Brain Res., 1095, No. 1, 207–210 (2006).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Kh. Salimgareeva.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 152, No. 9, pp. 281–285, September, 2011

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salimgareeva, M.K., Yamidanov, R.S., Vakhitova, Y.V. et al. Mechanisms of Action of Ladasten: Activation of Gene Expression for Neurotrophins and Mitogen-Activated Kinases. Bull Exp Biol Med 152, 313–317 (2012). https://doi.org/10.1007/s10517-012-1516-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-012-1516-z

Key Words

Navigation